Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization

BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization

Sep 08, 2020
|
staff reporter

NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations for BillionToOne's Sanger sequencing-based SARS-CoV-2 test, as well as an antibody test for the virus developed by South Korean diagnostics firm Sugentech.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Italy Seeks to Manufacture Vaccines

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

Fetal Tissue Research Restrictions Reversed

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

Funds for Viral Genomic Surveillance

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

PLOS Papers on Aicardi-Goutières Syndrome, COVID-19 in Colombian Amazon, Cancer MicroRNAs

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.

Apr
21
Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
22
Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

What's Popular?

In Molecular Diagnostics

  1. Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC

  2. Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

  3. Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

    Premium

  4. Women's Health Startup Adyn Raises $2.5M in Seed Funding

  5. Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.